School: Hope, masks over 6 years and controls – Politics

For the government “the reopening of schools is fundamental. But in complete safety”, constantly monitoring the epidemiological picture. Minister of Health Roberto Speranza says it in an interview with the Messenger. The investments “will serve the staff and also to find premises where they are insufficient. We will have to avoid gatherings even with staggered entrances if necessary”. Today “there is a Dpcm that provides for the use of masks in indoor places open to the public. From six years upwards. Two weeks before the start of the lessons we will evaluate the situation with the CTS” and “we could also think about measures different from region to region. ” There will also be constant medical checks.

For employee swabs, two CTS ideas are worked on: “serological tests for staff before reopening; sample molecular swabs during the school year”. Coming to the new outbreaks, “they tell us that the virus has not disappeared, but also that we have a faster and more effective monitoring system in the regions that allows us to identify problems”. We must continue “with respect for essential rules such as spacing, the use of masks and hand hygiene”. He is passing a message “that the virus is won, it is not like that. I appeal to everyone, we must win this challenge”. In the world “we are registering between 150 thousand and 180 thousand infected per day, there have never been so many” and for Italy “the Dpcm remains valid which provides, until July 15, mandatory quarantine for those coming from non-European countries”.

To counter a possible second wave “we have allocated 3.25 billion euros only in the relaunch decree”. Territorial health, prevention are being strengthened, “there are many more intensive care places, in three months we have hired 28,182 doctors, nurses and health workers”. As for the vaccine “Italy is at the heart of the challenge. With Germany, France and the Netherlands we have invested in the most promising vaccine candidate, developed by the University of Oxford, with the multinational AstraZeneca” and the participation of Italian excellence. If it arrives, “in times that are unprecedented for rapidity, the Italians will have it and will have it for free”.